Skip to main content
Type at least 3 characters

41 articles

Clinical Trial

Accepted on 26 Jun 2025

Safety and Immunogenicity of a Recombinant Double-Mutant Heat-Labile Toxin (dmLT) Derived from Enterotoxigenic Escherichia coli (ETEC) in Healthy Bangladeshi Adults delivered by three different routes

in Pathogenesis, Vaccines, and Immunity of Bacterial Infections

  • Taufiqur Rahman Bhuiyan
  • Farhana Khanam
  • Salima Raiyan Basher
  • Pinki Dash
  • Mohiul Islam Chowdhury
  • Shahinur Haque
  • Nabila Binte Harun
  • Aklima Akter
  • Polash Chandra Karmakar
  • Al Hakim
Frontiers in Bacteriology
doi 10.3389/fbrio.2025.1567791